6Suppliers
15Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

United Therapeutics Corporation (UTHR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships
3Distinct source URLs
9High confidence
0.748Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

United Therapeutics Corporation Suppliers

TickerNameConfidenceEvidence
CITIBANK-N-A CITIBANK-N-A 92% On March 9, 2026, the Company entered into two accelerated share repurchase agreements (the ASR Agreements ) with Citibank, N.A. ( Citi ) to repurchase approximately $1.5 billion in the aggregate of …
RAREGEN-LLC RAREGEN-LLC 80% In April 2019, Sandoz Inc. ( Sandoz ) and its marketing partner RareGen, LLC (now known as Liquidia PAH, LLC, a subsidiary of Liquidia Corporation) ( RareGen ), filed a complaint in the U.S. District…
SMITHS-MEDICAL-ASD-INC SMITHS-MEDICAL-ASD-INC 80% In April 2019, Sandoz Inc. ( Sandoz ) and its marketing partner RareGen, LLC (now known as Liquidia PAH, LLC, a subsidiary of Liquidia Corporation) ( RareGen ), filed a complaint in the U.S. District…
BETA BETA Technologies, Inc. 72% Reciprocal relationship from BETA graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from BETA graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from BETA g…
CTNM Contineum Therapeutics, Inc. 72% Reciprocal relationship from CTNM graph: om, or engaging in the sale or supply of products and services to, U.S. sanctioned countries, governments, persons and entities. Violations of Trade Laws can …
SUPN Supernus Pharmaceuticals, Inc. 72% Reciprocal relationship from SUPN graph: .e., at the time of sale to wholesalers/distributors). This liability is recorded as a reduction to gross product sales, and an increase in Accrued product re…

United Therapeutics Corporation Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-JUSTICE USGOV-DEPARTMENT-OF-JUSTICE 95% USAspending awards from Department of Justice: $87,006 across 2 awards. 15B50525F00000191 OPSUMIT 10MG-QTY 4 @ $6,270.03 ADEMPAS 1MG, QTY 1 @ $12,153.05 REMODULIN 5MG/ML INJ 20ML VIAL, QTY 1 @ $6,206…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $651,394 across 8 awards. 36C26124N0646 TYVASO; 36C26024F0248 TYVASO; 36C26026F0064 TYVASO KITS & CARTRIDGES | Qwen corrected direction: Explic…
DISTRIBUTOR-1 DISTRIBUTOR-1 90% We recorded revenue from two distributors in the United States that exceeded ten percent of total revenues.
DISTRIBUTOR-2 DISTRIBUTOR-2 90% We recorded revenue from two distributors in the United States that exceeded ten percent of total revenues.
CVS CVS Health Corporation 72% usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine…
CVS CVS Health Corporation 72% Reciprocal relationship from CVS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CVS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CVS grap…
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% lement of the 2025 Uncollared ASR occurred in November 2025, and we received an additional 3,882 shares of our common stock upon settlement. The final settlement of the 2025 Collared ASR occurred in …
CRS Carpenter Technology Corporation 62% Reciprocal relationship from CRS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CRS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CRS grap…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% companies. If we are not able to successfully identify, finance, consummate, and/or integrate acquisitions, our business operations and financial position could be adversely affected. We seek to expa…
LIQT LiqTech International, Inc. 62% Reciprocal relationship from LIQT graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from LIQT graph: Reciprocal relationship from UTHR graph: usion devices, including the Remuni…
LIQUIDIA-PAH-LLC LIQUIDIA-PAH-LLC 62% usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine…
LIQUIDIA-TECHNOLOGIES-INC LIQUIDIA-TECHNOLOGIES-INC 62% usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine…
PHILLIPS-MEDISIZE-CORP PHILLIPS-MEDISIZE-CORP 62% manufacturers that supply them. Lilly manufactures and supplies Adcirca for us. We use Lilly’s pharmaceutical wholesaler network to distribute Adcirca. If Lilly is unable to manufacture or supply Adc…
RAREGEN-LLC RAREGEN-LLC 62% usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine…
SMITHS-MEDICAL-ASD-INC SMITHS-MEDICAL-ASD-INC 62% usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine…

United Therapeutics Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
UTHR-DEBT-13272 Xbrl Convertible 90% xbrl convertible detail from xbrl 2016-12-31.

United Therapeutics Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for United Therapeutics Corporation.

United Therapeutics Corporation Ownership

HolderNameConfidenceEvidence
UTHR-OWNER-AVORO-CAPITAL-ADVISORS-LLC Avoro Capital Advisors LLC 90% 13F overlay lists Avoro Capital Advisors LLC as top holder; 859 tracked holders.

United Therapeutics Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
LLY Eli Lilly and Company 100.00 2
ELV Elevance Health, Inc. 100.00 2
GOSS Gossamer Bio, Inc. 100.00 2
LIQT LiqTech International, Inc. 100.00 1 ['customer']
NVSEF Novartis AG 100.00 2
AZN AstraZeneca PLC 100.00 2
CRS Carpenter Technology Corporation 100.00 1 ['customer']
GPCR Structure Therapeutics Inc. 100.00 2
GWW W.W. Grainger, Inc. 100.00 2
JNJ Johnson & Johnson 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
MCK McKesson Corporation 100.00 2
GSK GSK plc 100.00 2
BETA BETA Technologies, Inc. 100.00 1 ['supplier']
SUPN Supernus Pharmaceuticals, Inc. 100.00 1 ['supplier']
CAH Cardinal Health, Inc. 100.00 2
AIRO AIRO Group Holdings, Inc. 50.00 2
BLSH Bullish 50.00 2
BRBI BRBI BR Partners S.A. 50.00 2
BCO The Brink's Company 50.00 2
🔐
UTHR
Unlock UTHR Supply Chain Data
Verified relationships include:
CITIBANK-N-ACITIBANK-N-ASupplier92%
RAREGEN-LLCRAREGEN-LLCSupplier80%
USGOV-DEPARTMENT-OF-JUSTICEUSGOV-DEPARTMENT-OF-JUSTICECustomer95%
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRSUSGOV-DEPARTMENT-OF-VETER…Customer95%
+19 more relationships locked
Subscribe — View plans →